CCL22 and cystic fibrosis: A study has shown higher levels of inflammatory mediators, such as granulocyte-macrophage colony-stimulating factor (GM-CSF), macrophage-derived chemokine (MDC), and macrophage inflammatory protein1-β (MIP-1β) after CF-LVAD implantation [124].